BEUDAMED
    10 results · 23ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    ACON UTI URINARY TRACT INFECTION TEST STRIPS

    FDA 510(k)
    FDA Class 1 ·Hematology

    TIMX SPINAL SYSTEMS

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    BUTLER NUCARE ROOT CONDITIONER WITH NOVAMIN

    FDA 510(k)
    FDA Class 2 ·Dental

    UNKNOWN STRYKER LONG GAMMA NAIL LOT#K0B4A9D

    FDA Adverse Event
    Injury ·STRYKER TRAUMA KIEL·Product code HSB·August 11, 2016

    CP87170 DE MUENCHEN

    FDA Adverse Event
    Death ·SORIN GROUP ITALIA·Product code DTZ·July 15, 2011

    LIBERTY CYCLER SET, SINGLE CONN./EXT DL

    FDA Adverse Event
    Malfunction ·ERIKA DE REYNOSA, S.A. DE C.V.·Product code FKX·April 11, 2013

    PRECISE RX NITINOL STENT

    FDA Adverse Event
    Death ·CORDIS DE MEXICO·Product code NIM·June 17, 2008

    SWAN-GANZ CCO/VIPTHERMODILUTION CATHETER WITH AMC THROMBOSHIELD

    FDA Adverse Event
    Malfunction ·EDWARDS LIFESCIENCES, PR·Product code KRA·April 19, 2011

    Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

    FDA Enforcement
    Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

    CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

    FDA Enforcement
    Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015